Navigation Links
Ajanta Launches World's First Once-A-Day Nimesulide Oral Formulation

The Mumbai-based Ajanta Pharmaceuticals (APL) has launched its once-a-day 200mg controlled release nimesulide brand Nimlodi for arthritis. Nimlodi, which was developed by the Company through new drug delivery system, is the world's first once-a-day nimesulide brand for the treatment of arthritis. Ajanta, which manufactures both Allopathic and Ayurvedic medicines, developed this oral formulation in its fully integrated research and development centre at Kandivali in Mumbai. //

Since the brand received marketing approval from the Drug Controller General of India last month, it has been manufactured at Ajanta's Aurangabad factory. Nimlodi is marketed under the Ethicare division of Ajanta and the Company has already filed a patent application for the product. Nimlodi becomes the second most important product in the Ajanta portfolio after Carofit for which it has a global patent. Currently, the nimesulide market in India is worth Rs. 200 crore.

Ajanta, which has been conducting aggressive research for development of novel oral products and improved formulations, is looking for international partnerships in marketing the product all over the world.


'"/>




Page: 1

Related medicine news :

1. Serum Institute Launches New Tetanus-Diphtheria Vaccine
2. Scottish Health Minister Launches Organ Donor Plan
3. Pfizer Launches Viagra For Lung Disease In UK
4. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
5. PM Launches Healthcare Foundation For India
6. African Union Launches A Programme On Acceleration of HIV Prevention
7. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
8. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
9. The British Medical Journal Launches A Health Website
10. APEC Launches Bird Flu Exercise
11. Melbourne University Launches Plan To Produce More Caring Doctors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: